Print

IGBA’s CEO Advisory Committee advances strategic focus on access to medicines (May 2024)

Chief Executive Officers of the world’s largest generic and biosimilar medicines companies met in Vienna on 15 May 2024 to provide strategic advice to the International Generic and Biosimilar Medicines Association (IGBA). The generics and biosimilars sector, which supplies 70 to 90% of prescribed medicines around the world, is united in seeking to enable innovation and competition to improve patients’ access to quality-assured, safe and cost-effective medicines.

Read More

Share this page!

Contact Info

IGBA | INTERNATIONAL GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION

C/O DYN SA
Rue de Cornavin 11
1201 Geneva, Switzerland

E-mail: 
This email address is being protected from spambots. You need JavaScript enabled to view it.  

Follow us on: Twitter - LinkedIn - YouTube

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our Privacy Policy.

I accept cookies from this site